Navigation Links
Sysmex Customer Satisfaction Ranks Highest in Independent Market Research
Date:2/24/2009

IMV ServiceTrak(TM) and MD Buyline Hematology Results Are In

MUNDELEIN, Ill., Feb. 24 /PRNewswire/ -- Sysmex America, Inc., a leading medical diagnostic instrument manufacturer and laboratory information systems developer today announced that Sysmex hematology instruments have been ranked best in industry for instrument reliability for its ninth consecutive year according to IMV's 2008 ServiceTrak(TM) report. In this annual report, Sysmex also ranked first in 21 (twenty-one) of the 30 (thirty) survey factors, including all five OEM (Original Equipment Manufacturer) service performance factors and all five manufacturer and instrument performance factors. The IMV ServiceTrak survey respondents include clinical laboratory department supervisors, laboratory managers, and technologists chosen at random from hospitals of varying sizes from across the country. Sysmex hematology instruments also ranked first in customer satisfaction in MD Buyline's January 2009 User Satisfaction Ratings. MD Buyline survey respondents include technologists and clinicians from hospitals and clinical reference laboratories located throughout the United States.

"In today's tougher economic environment, clinical laboratories must aggressively seek core laboratory efficiency that ultimately contributes to the hospital's overall healthcare efficiency. Indicators such as IMV ServiceTrak and MD Buyline results are crucial information for clinical laboratories," said John Kershaw, President, Sysmex America, Inc. "For example, instrument reliability is a performance indicator that directly affects efficiency in patient care areas, including the emergency department, where speed is essential and operational costs are high," said Kershaw.

Instrument reliability also impacts clinical laboratory performance metrics such as results turnaround time and repeat rate. Switching to backup analyzers could create issues with shifting normal ranges and consistency of results used in patient trending analysis. Therefore, clinical laboratories will want to assess their instrument capability relative to their effect on service lines, care pathways, medical errors and patient flow, said Kershaw.

"Regardless of the healthcare industry's economic concerns, we know our customers must provide high quality care for their patients. As a healthcare partner to many of the nation's healthcare facilities, we are honored that our hematology instruments have met their needs in reliability and performance expectations," added Kershaw.

For more information about Sysmex hematology instruments and services, visit www.sysmex.com/usa.

About Sysmex America, Inc.

Sysmex America, Inc., the U.S. headquarters of Sysmex Corporation (Kobe, Japan), is a world leader in clinical laboratory systemization and solutions, including clinical diagnostics, automation and information systems. Serving customers for over 35 years, Sysmex focuses on extending the boundaries of diagnostic science while providing the management information tools that make a real difference in clinical and operational results for people worldwide. For more information about Sysmex, please visit www.sysmex.com/usa.


'/>"/>
SOURCE Sysmex America, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Sysmex America to Release e-Verify(TM), Powered By SNCS(TM)
2. Sysmex Announces Brand Change
3. Sysmex America to Enable Prolonged Hematology Instrument Uptime for Hagerstown Medical Laboratory With 1,000th SNCS Activation
4. Sysmex America Receives FDA Clearance for XE-5000(TM) Hematology Analyzer
5. Sysmex America Awarded Hematology Contract by Amerinet
6. Stop & Shop Alerts Customers to Voluntary Recall by Northern Star Company
7. EMSI Realigns Internal Divisions for More Effective Focus on Customers
8. Sodexo Partnership With The Beryl Companies Breaks Down Barriers to Better Customer Service in Healthcare
9. Compass Pharma Services Offers Microfill Capabilities to Contract Pharmaceutical Packaging Customers
10. Roche Announces Significant Price Reduction of Two ACCU-CHEK(R) Glucose Monitoring Kits to Help Customers With Diabetes During These Difficult Economic Times
11. Caremark Customer Care Centers Recognized for Customer Satisfaction Excellence by J.D. Power and Associates Certified Call Center Program(SM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... ... ... As part of the nationwide Days of Remembrance effort led by the United ... persecution, Center for Medicine after the Holocaust (CMATH) announced that it will ... and Poland next week. , The Fourth Biennial CMATH Champions Trip to Germany and ...
(Date:4/24/2017)... ... , ... Today, Bright Pink , a national non-profit organization focusing on the prevention and ... , Bright Pink is proud to announce Katie Thiede as their new Chief Executive Officer. ... as Chairman of the Board and launched a national search to find a visionary ...
(Date:4/24/2017)... ... April 24, 2017 , ... Veteran Theresa James awoke to the ... life forever. , In “Healing Tears,” James depicts every parent’s worst nightmare, when her ... I began journaling conversations and situations throughout my divorce,” James said. “After the death ...
(Date:4/24/2017)... ... 2017 , ... The world-class designers of Happy Gadget Alert ... lifesaving device for the everyday use of parents worldwide. It is a lightweight, ... a child’s vital signs, and detect unusual symptoms or physical patterns. This innovative ...
(Date:4/24/2017)... ... April 24, 2017 , ... symplrTM, a leading provider of ... that Kyle Allain has joined the company as Vice President and General Manager ... provider, payor and managed care solutions. , A seasoned executive with more ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 19, 2017 Global Prostate Cancer Therapeutics ... the prostate cancer therapeutics market analyzes the current ... prevalence of prostate cancer, launch of promising emerging ... of new drugs & therapeutic biological products, and ... to lesser side effects are some of the ...
(Date:4/19/2017)... , April 19, 2017  Sorrento Therapeutics, Inc. ... clinical-stage biopharmaceutical company developing new treatments for cancer ... closing of its previously announced underwritten public offering ... a public offering price of $2.00 per share, ... offering expenses payable by Sorrento.  The net proceeds ...
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-naïve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
Breaking Medicine Technology: